Display options
Cite
George T, Mandell BF. Gout in the transplant patient. J Clin Rheumatol. 1995;1(6):328-34doi: 10.1097/00124743-199512000-00003.
George, T., & Mandell, B. F. (1995). Gout in the transplant patient. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 1(6), 328-34. https://doi.org/10.1097/00124743-199512000-00003
George, T, and Mandell, B F. "Gout in the transplant patient." Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases vol. 1,6 (1995): 328-34. doi: https://doi.org/10.1097/00124743-199512000-00003
George T, Mandell BF. Gout in the transplant patient. J Clin Rheumatol. 1995 Dec;1(6):328-34. doi: 10.1097/00124743-199512000-00003. PMID: 19078010.
Copy Download .nbib Format: NLM
Share it on

J Clin Rheumatol. 1995 Dec;1(6):328-34. doi: 10.1097/00124743-199512000-00003.

Gout in the transplant patient.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

T George, B F Mandell

Affiliations

  1. Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio.

PMID: 19078010 DOI: 10.1097/00124743-199512000-00003

Abstract

Patients treated with cyclosporine after organ transplantation are at particular risk for the development of hyperuricemia and tophaceous gout. The appearance of tophi or clinical gout can occur within a short time of initiation of cyclosporine therapy. Treatment decisions for the often accelerated and severe gouty arthritis must take into consideration numerous drug interactions as well as the degree of allograft dysfunction, or renal insufficiency due to the effects of disease or medication.

Publication Types